Hereditary Angioedema

Under construction / Forgotten

This article was marked by its author as Under construction, but the last edit is older than 30 days. If you want to edit this page, please try to contact its author first (you fill find him in the history). Watch the discussion as well. If the author will not continue in work, remove the template {{Under construction}} and edit the page. Last update: Thursday, 05 May 2022 at 1.15 pm.

This article has been translated from WikiSkripta; the translation needs to be checked.

This article has been translated from WikiSkripta; the formatting needs to be checked.

This article has been translated from WikiSkripta; ready for the editor's review.

Swollen hand during a hereditary angioedema attack

Hereditary angioedema (C1 inhibitor deficiency, OMIM: 106100) is a genetic disease of the immune system with autosomal dominant inheritance. This is not a classic immunodeficiency, in which the affected individual would be exposed to a higher risk of infectious disease, but it is a hereditary disease of the immune system, where a mutation in the gene for one of the components of the immune system damages its carrier.

Pathogenesis

The mutation affects the complement component C1 inhibitor gene (C1-INH, localization 11q11-q13.1). The product of the mutated gene is either not formed at all or is non-functional. This means that every stimulus (albeit minimal and harmless such as a minor injury) leads to the activation of the entire complement cascade, the clinical manifestations are responsible for increased bradykinin production, which is normally regulated by inhibition of prekallikrein to kallikrein conversion by C1-INH.

Clinical picture

Externally, the disease manifests itself in swelling of the subcutaneous tissue and mucous membranes, which are pale, itchy, without a local increase in temperature. Swelling of the mucous membranes of the respiratory tract can be dangerous, gastrointestinal mucosa can cause indigestion, in severe form pain and partial intestinal obstruction and mimic a sudden abdominal event, urinary tract mucosa is at risk of urinary retention.

The disease has a later onset, sometimes in adulthood.

Diagnosis

The diagnosis is based on the demonstration of low levels of the C4 component of complement (due to consumption) and very low (in the non-functional form of C1-INH also normal or high) levels of C1-INH.

Differential diagnosis

It is necessary to differentiate the acquired forms differentially - paraneoplastic (consumption of C1-INH in tumor tissue), parainfectious (rarely in Hellicobacter pylori infection) and drug (in ACEI therapy up to 0.3−1 %)

Therapy

The B2R receptor antagonist bradykinin is used in acute treatment.- icatibant s.c. and i.v. C1-INH substitution. Antifibrinolytics (tranexamic acid) and danazol (ethinyltestosterone derivative) are used for long-term prophylaxis.

Sources

• ŠÍPEK, Antonín. Geneticky podmíněné poruchy imunitního systému [online]. The last revision 9. 6. 2006, [cit. 4. 1. 2010]. <http://www.genetika-biologie.cz/primarni-imunodeficience>.

References

• HAKL, Roman – KUKLÍNEK, Pavel. Hereditární angioedém v teorii a praxi. Practicus [online]. 2015, y. 14, vol. 5, p. 9-10, Available from <http://www.practicus.eu>. ISSN 1213-8711. 

• BARTŮŇKOVÁ, Jiřina. Imunodeficience. 1. edition. Praha : Grada, 2002. 228 pp. ISBN 80-247-0244-4.

• GUTOVÁ, Václava. Současné možnosti léčby projevů hereditárního angioedému. Remedia [online]. 2012, y. 2012, vol. 6, p. 393-397, Available from <http://www.remedia.cz/Clanky/Farmakoterapie/Soucasne-moznosti-lecby-projevu-hereditarniho-angioedemu/6-L-1oM.magarticle.aspx>. ISSN 2336-3541. 

Kategorie:Imunologie Kategorie:Genetika Kategorie:Dermatovenerologie